Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Mice Model Industry

      Global Mice Model Market to Reach $2 Billion by 2027


      News provided by

      Reportlinker

      Sep 30, 2020, 09:40 ET

      Share this article

      Share this article


      NEW YORK, Sept. 30, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for Mice Model estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 6.3% over the analysis period 2020-2027. CRISPR/CAS9, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$697.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Microinjection segment is readjusted to a revised 5.7% CAGR for the next 7-year period.

      Read the full report: https://www.reportlinker.com/p05957356/?utm_source=PRN

      The U.S. Market is Estimated at $351.4 Million, While China is Forecast to Grow at 9.7% CAGR

      The Mice Model market in the U.S. is estimated at US$351.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$432.5 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

      Embryonic Stem Cell Injection Segment to Record 5.9% CAGR

      In the global Embryonic Stem Cell Injection segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$184.5 Million in the year 2020 will reach a projected size of US$266.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$269.6 Million by the year 2027, while Latin America will expand at a 7.1% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 397-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

      Competitors identified in this market include, among others,

      • Charles River Laboratories International, Inc.
      • Envigo, Inc.
      • Genoway S.A.
      • Harbour Antibodies BV
      • Horizon Discovery Group PLC
      • inGenious Targeting Laboratory, Inc.
      • Janvier Labs
      • Laboratory Corporation of America Holdings (LabCorp)
      • Taconic Biosciences, Inc.
      • The Jackson Laboratory
      • Trans Genic, Inc.

      Read the full report: https://www.reportlinker.com/p05957356/?utm_source=PRN

      I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

      II. EXECUTIVE SUMMARY

      1. MARKET OVERVIEW
      Impact of Covid-19 and a Looming Global Recession
      Global Competitor Market Shares
      Mice Model Competitor Market Share Scenario Worldwide (in %):
      2018E

      2. FOCUS ON SELECT PLAYERS

      3. MARKET TRENDS & DRIVERS

      4. GLOBAL MARKET PERSPECTIVE
      Table 1: World Current & Future Analysis for Mice Model by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 2: World Historic Review for Mice Model by Geographic
      Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
      America, Middle East and Africa Markets - Independent Analysis
      of Annual Sales in US$ Thousand for Years 2012 through 2019

      Table 3: World 15-Year Perspective for Mice Model by Geographic
      Region - Percentage Breakdown of Value Sales for USA, Canada,
      Japan, China, Europe, Asia-Pacific, Latin America, Middle East
      and Africa Markets for Years 2012, 2020 & 2027

      Table 4: World Current & Future Analysis for CRISPR/CAS9 by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 5: World Historic Review for CRISPR/CAS9 by Geographic
      Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
      America, Middle East and Africa Markets - Independent Analysis
      of Annual Sales in US$ Thousand for Years 2012 through 2019

      Table 6: World 15-Year Perspective for CRISPR/CAS9 by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 7: World Current & Future Analysis for Microinjection by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 8: World Historic Review for Microinjection by Geographic
      Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
      America, Middle East and Africa Markets - Independent Analysis
      of Annual Sales in US$ Thousand for Years 2012 through 2019

      Table 9: World 15-Year Perspective for Microinjection by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 10: World Current & Future Analysis for Embryonic Stem
      Cell Injection by Geographic Region - USA, Canada, Japan,
      China, Europe, Asia-Pacific, Latin America, Middle East and
      Africa Markets - Independent Analysis of Annual Sales in US$
      Thousand for Years 2020 through 2027

      Table 11: World Historic Review for Embryonic Stem Cell
      Injection by Geographic Region - USA, Canada, Japan, China,
      Europe, Asia-Pacific, Latin America, Middle East and Africa
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 12: World 15-Year Perspective for Embryonic Stem Cell
      Injection by Geographic Region - Percentage Breakdown of Value
      Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
      Latin America, Middle East and Africa for Years 2012, 2020 &
      2027

      Table 13: World Current & Future Analysis for Nuclear Transfer
      by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 14: World Historic Review for Nuclear Transfer by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 15: World 15-Year Perspective for Nuclear Transfer by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 16: World Current & Future Analysis for Other
      Technologies by Geographic Region - USA, Canada, Japan, China,
      Europe, Asia-Pacific, Latin America, Middle East and Africa
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2020 through 2027

      Table 17: World Historic Review for Other Technologies by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 18: World 15-Year Perspective for Other Technologies by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 19: World Current & Future Analysis for Breeding by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 20: World Historic Review for Breeding by Geographic
      Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
      America, Middle East and Africa Markets - Independent Analysis
      of Annual Sales in US$ Thousand for Years 2012 through 2019

      Table 21: World 15-Year Perspective for Breeding by Geographic
      Region - Percentage Breakdown of Value Sales for USA, Canada,
      Japan, China, Europe, Asia-Pacific, Latin America, Middle East
      and Africa for Years 2012, 2020 & 2027

      Table 22: World Current & Future Analysis for Cryopreservation
      by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 23: World Historic Review for Cryopreservation by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 24: World 15-Year Perspective for Cryopreservation by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 25: World Current & Future Analysis for Genetic Testing
      by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 26: World Historic Review for Genetic Testing by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 27: World 15-Year Perspective for Genetic Testing by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 28: World Current & Future Analysis for Other Services by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 29: World Historic Review for Other Services by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 30: World 15-Year Perspective for Other Services by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 31: World Current & Future Analysis for Oncology Studies
      by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 32: World Historic Review for Oncology Studies by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 33: World 15-Year Perspective for Oncology Studies by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 34: World Current & Future Analysis for Immunology &
      Inflammation Studies by Geographic Region - USA, Canada, Japan,
      China, Europe, Asia-Pacific, Latin America, Middle East and
      Africa Markets - Independent Analysis of Annual Sales in US$
      Thousand for Years 2020 through 2027

      Table 35: World Historic Review for Immunology & Inflammation
      Studies by Geographic Region - USA, Canada, Japan, China,
      Europe, Asia-Pacific, Latin America, Middle East and Africa
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 36: World 15-Year Perspective for Immunology &
      Inflammation Studies by Geographic Region - Percentage
      Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa for Years
      2012, 2020 & 2027

      Table 37: World Current & Future Analysis for Diabetes Studies
      by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 38: World Historic Review for Diabetes Studies by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 39: World 15-Year Perspective for Diabetes Studies by
      Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 40: World Current & Future Analysis for Cardiovascular
      Studies by Geographic Region - USA, Canada, Japan, China,
      Europe, Asia-Pacific, Latin America, Middle East and Africa
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2020 through 2027

      Table 41: World Historic Review for Cardiovascular Studies by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 42: World 15-Year Perspective for Cardiovascular Studies
      by Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      Table 43: World Current & Future Analysis for Central Nervous
      System (CNS) Studies by Geographic Region - USA, Canada, Japan,
      China, Europe, Asia-Pacific, Latin America, Middle East and
      Africa Markets - Independent Analysis of Annual Sales in US$
      Thousand for Years 2020 through 2027

      Table 44: World Historic Review for Central Nervous System
      (CNS) Studies by Geographic Region - USA, Canada, Japan, China,
      Europe, Asia-Pacific, Latin America, Middle East and Africa
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 45: World 15-Year Perspective for Central Nervous System
      (CNS) Studies by Geographic Region - Percentage Breakdown of
      Value Sales for USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa for Years
      2012, 2020 & 2027

      Table 46: World Current & Future Analysis for Other Therapeutic
      Areas by Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2020 through 2027

      Table 47: World Historic Review for Other Therapeutic Areas by
      Geographic Region - USA, Canada, Japan, China, Europe,
      Asia-Pacific, Latin America, Middle East and Africa Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 48: World 15-Year Perspective for Other Therapeutic Areas
      by Geographic Region - Percentage Breakdown of Value Sales for
      USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
      Middle East and Africa for Years 2012, 2020 & 2027

      III. MARKET ANALYSIS

      GEOGRAPHIC MARKET ANALYSIS

      UNITED STATES
      Market Facts & Figures
      US Mice Model Market Share (in %) by Company: 2018 & 2027
      Market Analytics
      Table 49: USA Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 50: USA Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 51: USA 15-Year Perspective for Mice Model by Technology -
      Percentage Breakdown of Value Sales for CRISPR/CAS9,
      Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer
      and Other Technologies for the Years 2012, 2020 & 2027

      Table 52: USA Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 53: USA Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 54: USA 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 55: USA Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 56: USA Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 57: USA 15-Year Perspective for Mice Model by Therapeutic
      Area - Percentage Breakdown of Value Sales for Oncology
      Studies, Immunology & Inflammation Studies, Diabetes Studies,
      Cardiovascular Studies, Central Nervous System (CNS) Studies
      and Other Therapeutic Areas for the Years 2012, 2020 & 2027

      CANADA
      Table 58: Canada Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 59: Canada Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 60: Canada 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 61: Canada Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 62: Canada Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 63: Canada 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 64: Canada Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 65: Canada Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 66: Canada 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      JAPAN
      Table 67: Japan Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 68: Japan Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 69: Japan 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 70: Japan Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 71: Japan Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 72: Japan 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 73: Japan Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 74: Japan Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 75: Japan 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      CHINA
      Table 76: China Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 77: China Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 78: China 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 79: China Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 80: China Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 81: China 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 82: China Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 83: China Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 84: China 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      EUROPE
      Market Facts & Figures
      European Mice Model Market: Competitor Market Share Scenario:
      ( in %) for 2018 & 2027
      Market Analytics
      Table 85: Europe Current & Future Analysis for Mice Model by
      Geographic Region - France, Germany, Italy, UK, Spain, Russia
      and Rest of Europe Markets - Independent Analysis of Annual
      Sales in US$ Thousand for Years 2020 through 2027

      Table 86: Europe Historic Review for Mice Model by Geographic
      Region - France, Germany, Italy, UK, Spain, Russia and Rest of
      Europe Markets - Independent Analysis of Annual Sales in US$
      Thousand for Years 2012 through 2019

      Table 87: Europe 15-Year Perspective for Mice Model by
      Geographic Region - Percentage Breakdown of Value Sales for
      France, Germany, Italy, UK, Spain, Russia and Rest of Europe
      Markets for Years 2012, 2020 & 2027

      Table 88: Europe Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 89: Europe Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 90: Europe 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 91: Europe Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 92: Europe Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 93: Europe 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 94: Europe Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 95: Europe Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 96: Europe 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      FRANCE
      Table 97: France Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 98: France Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 99: France 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 100: France Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 101: France Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 102: France 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 103: France Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 104: France Historic Review for Mice Model by Therapeutic
      Area - Oncology Studies, Immunology & Inflammation Studies,
      Diabetes Studies, Cardiovascular Studies, Central Nervous
      System (CNS) Studies and Other Therapeutic Areas Markets -
      Independent Analysis of Annual Sales in US$ Thousand for Years
      2012 through 2019

      Table 105: France 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      GERMANY
      Table 106: Germany Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 107: Germany Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 108: Germany 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 109: Germany Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 110: Germany Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 111: Germany 15-Year Perspective for Mice Model by
      Service - Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 112: Germany Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 113: Germany Historic Review for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central
      Nervous System (CNS) Studies and Other Therapeutic Areas
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 114: Germany 15-Year Perspective for Mice Model by
      Therapeutic Area - Percentage Breakdown of Value Sales for
      Oncology Studies, Immunology & Inflammation Studies, Diabetes
      Studies, Cardiovascular Studies, Central Nervous System (CNS)
      Studies and Other Therapeutic Areas for the Years 2012, 2020 &
      2027

      ITALY
      Table 115: Italy Current & Future Analysis for Mice Model by
      Technology - CRISPR/CAS9, Microinjection, Embryonic Stem Cell
      Injection, Nuclear Transfer and Other Technologies -
      Independent Analysis of Annual Sales in US$ Thousand for the
      Years 2020 through 2027

      Table 116: Italy Historic Review for Mice Model by Technology -
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies Markets - Independent
      Analysis of Annual Sales in US$ Thousand for Years 2012 through
      2019

      Table 117: Italy 15-Year Perspective for Mice Model by
      Technology - Percentage Breakdown of Value Sales for
      CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection,
      Nuclear Transfer and Other Technologies for the Years 2012,
      2020 & 2027

      Table 118: Italy Current & Future Analysis for Mice Model by
      Service - Breeding, Cryopreservation, Genetic Testing and Other
      Services - Independent Analysis of Annual Sales in US$ Thousand
      for the Years 2020 through 2027

      Table 119: Italy Historic Review for Mice Model by Service -
      Breeding, Cryopreservation, Genetic Testing and Other Services
      Markets - Independent Analysis of Annual Sales in US$ Thousand
      for Years 2012 through 2019

      Table 120: Italy 15-Year Perspective for Mice Model by Service -
      Percentage Breakdown of Value Sales for Breeding,
      Cryopreservation, Genetic Testing and Other Services for the
      Years 2012, 2020 & 2027

      Table 121: Italy Current & Future Analysis for Mice Model by
      Therapeutic Area - Oncology Studies, Immunology & Inflammation
      Studies, Diabetes Studies, Cardiovascular Studies, Central

      Please contact our Customer Support Center to get the complete Table of Contents
      Read the full report: https://www.reportlinker.com/p05957356/?utm_source=PRN

      About Reportlinker
      ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

      __________________________
      Contact Clare: [email protected]  
      US: (339)-368-6001
      Intl: +1-339-368-6001

      SOURCE Reportlinker

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.